Virtual screening of GPCRs: an in silico chemogenomics approach

scientific article

Virtual screening of GPCRs: an in silico chemogenomics approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P818arXiv ID0801.4301
P8978DBLP publication IDjournals/bmcbi/JacobHSV08
P6179Dimensions Publication ID1022837599
P356DOI10.1186/1471-2105-9-363
P932PMC publication ID2553090
P698PubMed publication ID18775075
P5875ResearchGate publication ID23241131

P50authorBrice HoffmannQ57021498
Jean-Philippe VertQ41044597
P2093author name stringVéronique Stoven
Laurent Jacob
P2860cites workMolecular tinkering of G protein-coupled receptors: an evolutionary successQ24534016
Amino acid substitution matrices from protein blocksQ24563220
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptorQ24657484
Multiple sequence alignment with the Clustal series of programsQ24672842
GPCRDB information system for G protein-coupled receptorsQ24681765
Unbiased descriptor and parameter selection confirms the potential of proteochemometric modellingQ24805088
GLIDA: GPCR-ligand database for chemical genomic drug discoveryQ25257715
VMD: visual molecular dynamicsQ27860554
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsQ27861111
The Pharmacophore Kernel for Virtual Screening with Support Vector MachinesQ29038130
The druggable genomeQ29547361
Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levelsQ29615743
Predicting enzyme class from protein structure without alignments.Q30349733
An ontology for pharmaceutical ligands and its application for in silico screening and library designQ30838142
PREDICT modeling and in-silico screening for G-protein coupled receptors.Q31107931
Improved approach for proteochemometrics modeling: application to organic compound--amine G protein-coupled receptor interactionsQ33224561
G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validationQ33225065
One- to four-dimensional kernels for virtual screening and the prediction of physical, chemical, and biological properties.Q33276875
Chemogenomic approaches to drug discovery: similar receptors bind similar ligandsQ33285994
GPCR structure-based virtual screening approach for CB2 antagonist searchQ33288322
Protein function prediction via graph kernels.Q50747531
Graph kernels for molecular structure-activity relationship analysis with support vector machines.Q51633154
Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.Q51791975
The context-tree kernel for strings.Q51963075
An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application.Q51963840
The spectrum kernel: a string kernel for SVM protein classification.Q52043503
A bioavailability score.Q53622895
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor LigandsQ57838214
A discriminative framework for detecting remote protein homologiesQ62494112
Prediction of drug absorption using multivariate statisticsQ73126791
Assessing the performance of OMEGA with respect to retrieving bioactive conformationsQ78834325
A crystal clear view of the beta2-adrenergic receptorQ80657778
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptorQ81409742
A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptorsQ81494743
Molecular properties that influence the oral bioavailability of drug candidatesQ34130727
Profile-based string kernels for remote homology detection and motif extractionQ34444041
G protein-coupled receptors in major psychiatric disordersQ34578414
Sequence analyses of G-protein-coupled receptors: similarities to rhodopsinQ35081967
G-protein-coupled receptors: past, present and future.Q35566599
Orphan G protein-coupled receptors: targets for new therapeutic interventionsQ35794985
Graph kernels for chemical informaticsQ36255619
Targeting G protein-coupled receptor signaling in asthmaQ36530502
G protein coupled receptor structure and activationQ36692097
G-protein-coupled receptors: an updateQ36788551
Structural models of class a G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticityQ36825015
Chemogenomic approaches to rational drug designQ36833536
G protein-coupled receptors: in silico drug discovery in 3D.Q37388375
A structural alignment kernel for protein structuresQ38517015
A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptorsQ38561234
An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretionQ40418686
Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.Q40594026
Predicting protein--protein interactions from primary structureQ40710149
Mismatch string kernels for discriminative protein classificationQ42620879
Efficient peptide-MHC-I binding prediction for alleles with few known binders.Q42639862
Protein-ligand interaction prediction: an improved chemogenomics approach.Q42948052
Virtual screen for ligands of orphan G protein-coupled receptorsQ44096715
Property-based design of GPCR-targeted libraryQ44165334
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?Q44242205
Similarity metrics for ligands reflecting the similarity of the target proteinsQ44373337
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structureQ45029374
Collaborative filtering on a family of biological targets.Q45966036
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptorQ46120520
A physicogenetic method to assign ligand-binding relationships between 7TM receptorsQ46579290
Protein homology detection using string alignment kernelsQ48028746
A tree kernel to analyse phylogenetic profiles.Q48625579
Marginalized kernels for biological sequences.Q48625590
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjectG protein-coupled receptorQ38173
in silicoQ192572
virtual screeningQ4112105
P304page(s)363
P577publication date2008-09-06
P1433published inBMC BioinformaticsQ4835939
P1476titleVirtual screening of GPCRs: an in silico chemogenomics approach
P478volume9

Reverse relations

cites work (P2860)
Q33571101Application of kernel functions for accurate similarity search in large chemical databases.
Q41760025Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets
Q39411048Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets
Q42695674Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.
Q38915500CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions
Q30391368Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features
Q30361816Computational chemogenomics: is it more than inductive transfer?
Q30414815Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets
Q41875668Cross-pharmacology analysis of G protein-coupled receptors
Q57031084Efficient multi-task chemogenomics for drug specificity prediction
Q112623697Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity
Q38258721Feature Selection in the Tensor Product Feature Space.
Q21133651Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach
Q36379132Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel
Q34622472Learning a peptide-protein binding affinity predictor with kernel ridge regression
Q28545910Machine learning assisted design of highly active peptides for drug discovery
Q28751419Machine learning for in silico virtual screening and chemical genomics: new strategies
Q27027706Marine natural products as breast cancer resistance protein inhibitors
Q45943415Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Q45383758Modelling ligand selectivity of serine proteases using integrative proteochemometric approaches improves model performance and allows the multi-target dependent interpretation of features
Q38028542Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
Q54152494Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects
Q47428755Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods.
Q42948052Protein-ligand interaction prediction: an improved chemogenomics approach.
Q51319882Proteochemometric Modeling of the Interaction Space of Carbonic Anhydrase and its Inhibitors: An Assessment of Structure-based and Sequence-based Descriptors.
Q54152447Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets
Q30420578Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
Q30391031Structure-Based Approaches to Target Fishing and Ligand Profiling
Q38168576Support vector machines for drug discovery
Q27902317Target prediction utilising negative bioactivity data covering large chemical space
Q27687653Understanding functional residues of the cannabinoid CB1.

Search more.